Trying to get a straight answer on this: someone explain interval stretching to me like I have not read a paper in years. A written baseline — dose, date, weight,…
u/fabio_lehtinen
Contributes reviews on supplier material. Based in Monterrey.
member · joined 15 Jun 2025
Overview — page 3 of 3
comment on is it normal to get early fullness at week 64 in c/retatrutide · 8 points · 1 year ago
Agreed, and the framing that helps is: this is a phase 2 compound with phase 3 running. Everything else is inference.
comment on the handling question that gets asked weekly, answered properly in c/researchpeptides · 9 points · 1 year ago
the sequence is the product, everything else is packaging
comment on my TSH moved and I cannot work out whether ACHIEVE is why in c/orforglipron · 204 points · 1 year ago
Not convinced. Oral semaglutide is a peptide formulated with an absorption enhancer; the comparison you are making does not hold.
comment on someone explain interval stretching to me like I have not read a paper in years in c/tapering · 3 points · 1 year ago
What is prompting the decision — cost, supply, side effects, or something else?
comment on someone explain interval stretching to me like I have not read a paper in years in c/tapering · 25 points · 1 year ago
Went back on after eight months away. Nobody here made me feel bad about it, which mattered more than I expected.
comment on tried weight for 3 weeks. here is what happened. in c/dosinglogs · 1 points · 1 year ago
Adding the column everyone adds late — sleep.
Agreed — and the payoff genuinely arrives in month six, not week two.
comment on anyone else notice lost money kicking in around week 72 in c/darkspot · 49 points · 1 year ago
Yes. Buy small first. It is the cheapest lesson on the site and it keeps being learned the expensive way.
comment on my ferritin moved and I cannot work out whether tracking is why in c/dosinglogs · 8 points · 1 year ago
Contemporaneous or reconstructed?
comment on [Vendor] JEEP order #3 — Ireland, 21 days, no drama, receipts inside in c/intlshipping · 17 points · 1 year ago
origin, destination, carrier, month — post all four or the report is noise
comment on 3 months in and triple agonist is still the thing I get wrong in c/retatrutide · 513 points · 1 year ago
It is a triple agonist at the GLP-1, GIP and glucagon receptors. The glucagon arm is the genuinely novel component and it is the one with the least human outcome data behind it.
comment on [Discussion] ATTAIN is doing more work than we give it credit for in c/orforglipron · 1 points · 1 year ago
nothing containing this is approved anywhere yet
comment on TRIUMPH: what the trials say vs what this community says in c/retatrutide · 9 points · 1 year ago
Disagree.
discount_math_dm is right about the escalation being the variable. It explains most of the difficult reports here.
comment on [Discussion] we are measuring regain at the wrong time and calling it noise in c/tapering · 11 points · 1 year ago
This. Decide in advance what you are watching for. Deciding in the middle of it is much harder.
comment on anyone else notice triple agonist kicking in around week 65 in c/retatrutide · 126 points · 1 year ago
Are you tracking heart rate at all?
comment on anyone else notice lost money kicking in around week 95 in c/darkspot · 1 points · 2 years ago
accusing the wrong party and correcting it publicly is the best kind of post here
comment on the interval stretching thing finally clicked for me and I want to write it down in c/tapering · 12 points · 2 years ago
I would not treat appetite returning as a sign of doing it wrong. It is the expected sequence.
comment on am I the only one who found glucagon harder than the injections in c/retatrutide · 37 points · 2 years ago
The standing caveat, written out properly because it keeps getting compressed into a footnote.
Disagree with this specific inference. A 48-week readout does not tell you the shape of the curve after it.
comment on [Discussion] can we stop arguing about ATTAIN until somebody posts a number in c/orforglipron · 1 points · 2 years ago
daily dosing, not weekly, so the exposure profile is different
comment on switched from 10mg to 15mg and nausea got better, not worse in c/retatrutide · 132 points · 2 years ago
Push back: quoting the phase 2 headline as an expected outcome is not a fair reading of a small trial with wide intervals.
comment on switched from 10mg to 15mg and nausea got better, not worse in c/retatrutide · 526 points · 2 years ago
Read the phase 2 paper twice before ordering anything. Recommend that to anyone in this board: the error bars are the interesting part.